Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Arcus Biosciences, Inc. Director's Dealing 2020

Oct 15, 2020

31966_dirs_2020-10-15_fc0238ac-f4b4-46f7-a2aa-4f0eb093ad30.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Arcus Biosciences, Inc. (RCUS)
CIK: 0001724521
Period of Report: 2020-10-13

Reporting Person: Jaen Juan C. (Director, President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-10-13 Common Stock G 1207000 $0.00 Disposed 1572240 Indirect

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 189393 Direct

Footnotes

F1: Gift to various family trusts over which the reporting person has neither voting nor investment control.